Family Foundation Schuler serves as Executive at Transition Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Family Foundation Schuler has executed 8 insider transactions totaling $20.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 19, 2015 involved purchasing 1,664,840 shares valued at $5.5M.
Family Foundation Schuler currently holds 9,784,143 shares of Transition Therapeutics Inc. (TTHI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Family Foundation Schuler has been a net buyer of TTHI stock. They have purchased $20.7M and sold $0 worth of shares.
Family Foundation Schuler's most recent insider trade was on Jun 19, 2015, when they purchased 1,664,840 shares at $3.32 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 9, 2015 | HNSN | $15.0M | Purchase | 23,077 | $650.00 | Discretionary |
| Oct 30, 2014 | MBLX | $0 | Conversion | 23,400,000 | $N/A | Discretionary |
| Aug 25, 2014 | HNSN | $8.5M | Exercise | 7,488,188 | $1.13 | Discretionary |
| Dec 30, 2010 | TTHI | $60.9K | Purchase | 30,000 | $2.03 | Discretionary |
| Dec 13, 2010 | TTHI | $60.9K | Purchase | 30,000 | $2.03 | Discretionary |
| Dec 10, 2010 | TTHI | $17.9K | Purchase | 8,700 | $2.06 | Discretionary |